Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04363905
Other study ID # 012002
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date April 1, 2000
Est. completion date December 31, 2000

Study information

Verified date March 2022
Source Cornell University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The specific aims of the current study were: 1) To determine the prevalence of IDNA in a sample of Mexican women of reproductive age and 2) To determine how iron supplementation in IDNA women influences physical work capacity during submaximal exercise . The researchers hypothesized that marginally iron depleted women will have improved physical work capacity during submaximal intermittent exercise tests after dietary iron supplementation. However, no improvement in peak maximal oxygen consumption after dietary iron supplementation because they will remain non-anemic.


Description:

Recent estimates of the prevalence of anemia among non-pregnant Mexican women of reproductive age range from 15 percent for a nationally representative sample from the 1988 National Nutrition Survey to 29 percent for low socioeconomic women from the PROGRESA baseline survey of 1998 (Mexican Ministry of Health, unpublished report). The cause of most of this anemia is iron deficiency. It can be assumed that time between 15 and 30 percent of Mexican women also experience iron deficiency without also experiencing anemia. In some studies of anemic women, iron deficiency has been shown to result in reduced physical performance as measured by VO2max (the oxygen consumption at maximum physical exertion), presumably due to reduced oxygen (02) transport related to the reduced hemoglobin (Hb) concentration. However, no effects of iron deficiency have been shown on VO2max in women who were not anemic. Given that Hb concentration is not reduced in iron deficient non anemic women, it is expected that VO2max remains unaffected. However, this less severe form of iron deficiency may still affect physical performance. The important role of iron in the synthesis of many of the enzymes involved in oxidative metabolism suggests that moderate levels of iron deficiency may impair muscular energy transformation at levels of exertion that are not as severe as those reflected in VO2max. The choice of the appropriate sub maximal physical performance test is therefore critical to successful demonstration of the effects of moderate iron deficiency on response to exercise stress. In this study the investigators proposed to test the effects of iron deficiency on physical performance using a randomized double blind design that assigns marginally iron depleted, physically active women between 18 and 45 years to two treatments. One half of the women will be randomly assigned to a group that receives a daily oral iron supplement (20 mg of elemental iron as slow release ferrous sulfate) while the remaining women received a placebo. Investigators anticipated that iron supplementation would replete iron body stores in all women and increase Hb only in those who are marginally anemic. Investigators tested the physical performance response to iron treatment with two exercise tests. It was hypothesized that VO2max would not be affected by iron supplementation. A graded submaximal exertion test (30 60% of VO2max) to estimate energy expenditure (EE), gross efficiency (GE), and net efficiency (NE) was administered to test for an increase in work efficiency due to iron supplementation. This study has important implications for the definition of dietary iron requirements in this segment of the Mexican population. The physical performance test used in this study (EE, GE, and NE), while well recognized, have never been applied to this type of research question nor has it been examined in relation to endurance performance in Mexican women. Investigators believe that previous reliance on the VO2max test to measure performance has biased conclusions toward concern only for the anemic subject, while the less severe forms of iron deficiency have been considered benign. This study, if successful in supporting the stated hypotheses, will serve as further confirm the deleterious effects of iron deficiency without anemia and justify future research on more practical measures of performance related to female economic productivity and time and effort allocated to child care and household responsibilities.


Recruitment information / eligibility

Status Completed
Enrollment 68
Est. completion date December 31, 2000
Est. primary completion date August 31, 2000
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 18 Years to 45 Years
Eligibility Inclusion Criteria: - non-smoking Exclusion Criteria: - acute or chronic injury or illness at time of screening, hemolytic anemia - physician-diagnosed asthma, musculoskeletal problems, or eating disorders - pregnant or lactating, pregnant with the previous year - excessive alcohol consumption or recent use of recreational drugs - recent history of eating disorders, or use of prescription medications and/or vitamin or mineral supplements that would interfere with dietary iron absorption

Study Design


Intervention

Dietary Supplement:
Placebo
100 mg lactose per day for 6 weeks
Ferrous sulfate
20 mg per day of elemental iron for 6 weeks

Locations

Country Name City State
United States Cornell University Ithaca New York

Sponsors (2)

Lead Sponsor Collaborator
Cornell University Instituto Nacional de Salud Publica, Mexico

Country where clinical trial is conducted

United States, 

References & Publications (1)

Brutsaert TD, Hernandez-Cordero S, Rivera J, Viola T, Hughes G, Haas JD. Iron supplementation improves progressive fatigue resistance during dynamic knee extensor exercise in iron-depleted, nonanemic women. Am J Clin Nutr. 2003 Feb;77(2):441-8. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Marker of iron status: Hemoglobin g/L 6 weeks
Primary Marker of iron status: serum ferritin ug/L 6 weeks
Primary Marker of iron status: serum transferrin receptor mg/L 6 weeks
Primary Marker of iron status: serum iron umol/L 6 weeks
Primary Marker of iron status: total iron binding capacity umol/L 6 weeks
Primary Marker of iron status: transferrin saturation 6 weeks
Secondary Physical performance Submaximal and maximal cycling ergometry was used to assess physical performance 6 weeks
Secondary Fatigue resistance Maximal voluntary static contractions (MVCs) with dynamic knee extensions was used to assess fatigue 6 weeks
See also
  Status Clinical Trial Phase
Not yet recruiting NCT05869422 - Low-dose Iron Supplementation in Non-anaemic Iron-deficient Women N/A
Enrolling by invitation NCT05740462 - Hydroponic Fortification and Dietary App Effect on Nutrients Level (Harvest) N/A
Completed NCT04216030 - IP Peru, Bioavailability of Iron From Potatoes N/A
Not yet recruiting NCT06264687 - Hepcidin After Intravenous Iron Treatment
Completed NCT04735848 - Plasma Hepcidin Response to Differently Dosed Iron Supplements N/A
Completed NCT04465851 - Effect of Ferrous iROn and cUrcumin sTatus on Inflammatory and Neurotrophic markErs N/A
Completed NCT04636060 - Effectiveness of Low-dose Iron Treatment in Non-anaemic Iron-deficient Women N/A
Completed NCT05467423 - Effect of Low-dose Versus Standard-dose Iron Supplementation on the Gut Microbiome N/A
Completed NCT05257343 - Efficacy of a Low Dose, Oral, Liquid Iron Supplement on Restoring Inadequate Blood Iron to Normal Levels N/A
Completed NCT03670537 - Iron Parameters in Non-anemic First Trimester Gravidas
Recruiting NCT02949765 - Effects of a Dietary Approach to Iron Deficiency in Premenopausal Women Affected by Celiac Disease N/A
Completed NCT03228173 - Iron Deficiency in Female State Fair Attendees N/A
Completed NCT01383798 - How Does Iron Supplementation Affect Training and Performance in Female Collegiate Rowers? N/A
Active, not recruiting NCT05500014 - Effect of Altitude on Iron Absorption in Iron Depleted Women N/A
Completed NCT06021171 - Improving the Iron Status of Athletes With Pre-, Pro- and Synbiotics N/A
Active, not recruiting NCT04228627 - Ferritin Screening And IRon Treatment for Maternal Anemia and FGR Prevention Trial Phase 4